Cargando…
In Hot Pursuit of the First Vaccine Against Respiratory Syncytial Virus
Human respiratory syncytial virus (RSV) is the leading cause of severe lower respiratory tract infection, such as bronchiolitis, bronchitis, or pneumonia, in both infants and the elderly. Despite the global burden of diseases attributable to RSV infection, no clinically approved vaccine is available...
Autores principales: | Kim, Joo Young, Chang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951454/ https://www.ncbi.nlm.nih.gov/pubmed/27189271 http://dx.doi.org/10.3349/ymj.2016.57.4.809 |
Ejemplares similares
-
Need for a safe vaccine against respiratory syncytial virus infection
por: Kim, Joo-Young, et al.
Publicado: (2012) -
Developing Vaccines against Respiratory Syncytial Virus Infection
por: Chang, Jun
Publicado: (2011) -
Universal vaccine against respiratory syncytial virus A and B subtypes
por: Lee, Jeong-Yoon, et al.
Publicado: (2017) -
Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus
por: Jorquera, Patricia A., et al.
Publicado: (2016) -
Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced Diseases
por: Lee, Hyo-Jeong, et al.
Publicado: (2017)